Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/05/17
End: 01/31/19
Due: 01/31/20
Phase: N/A
Priority: Normal
Start: 12/31/16
End: 12/17/21
Due: 12/17/22
Phase: N/A
Priority: Normal
Start: 04/14/16
End: 01/15/18
Due: 01/15/19
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 01/31/17
Due: 01/31/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal Function | NCT02840812 | Zhejiang Medicine Co., Ltd. | user2@example.com | None | 2017-04-05 | 2019-01-31 | 2020-01-31 | - | - | 2025-07-14 |
| Vitamin E Versus Placebo for the Treatment of Non Diabetic Patients With Nonalcoholic Steatohepatitis | NCT02962297 | Zhejiang Medicine Co., Ltd. | user2@example.com | None | 2016-12-31 | 2021-12-17 | 2022-12-17 | - | - | 2025-07-14 |
| Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Moderate Impaired Hepatic Function | NCT02604498 | Zhejiang Medicine Co., Ltd. | user2@example.com | None | 2016-04-14 | 2018-01-15 | 2019-01-15 | - | - | 2025-07-14 |
| A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 Expression | NCT02512237 | Zhejiang Medicine Co., Ltd. | user2@example.com | None | 2016-03-31 | 2017-01-31 | 2018-01-31 | - | - | 2025-07-14 |